Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-...
Q2 2026
Aug 3, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 3, 2025